EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study

Silvia Corcione, Simone Mornese Pinna, Antonio Vena, Michela Schenone, Maura Sanino, Renato Pascale, Emanuele Pivetta, Daniele Roberto Giacobbe, Maddalena Giannella, Nour Shbaklo iD, Francesca Giovannenze, Nicholas Geremia iD und 11 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0317540 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, 2025. Verfasst von Silvia Corcione und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Bacteremia, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This large, multicenter, Italian retrospective study aimed to describe clinical characteristics and risk factors associated with 30-day mortality in patients with Pseudomonas aeruginosa bloodstream infections (PA-BSI) admitted to internal medicine wards (IMW). To enhance clinical decision-making, we also developed and internally validated a bedside prognostic model to predict the 30-day mortality risk.

Methods

We conducted a retrospective, multicenter cohort study across 14 public hospitals in Italy, analyzing all adult patients admitted to IMW with PA-BSI between 2021 and 2022.

Results

Out of 285 eligible patients with PA-BSI, the median age was 73 years, and septic shock occurred in 13.3% of cases. Less than 5% of PA-BSI were caused by difficult-to-treat resistant P. aeruginosa (DTR-PA). Encouragingly, appropriate empiric therapy was administered in 69.8% of patients, yet the overall 30-day mortality remained 22.5%. Cox regression analysis identified age, and urinary catheter use as significant risk factors for mortality. Conversely, adequate source control and targeted therapy emerged as protective factors. Multivariate analysis confirmed septic shock at bloodstream infection onset (HR 6.96; 95% CI, 1.72–28.12) as a strong independent predictor of mortality, whereas effective source control (HR 0.152; 95% CI, 0.039–0.59) significantly improved survival odds. Using these insights, we developed a practical prognostic model capable of estimating the 30-day mortality risk, providing clinicians with a valuable predictive tool at the bedside.

Conclusions

PA-BSI in IMWs is characterized by a relatively low incidence of septic shock and rate of resistance, alongside high rates of appropriate empiric therapy. Despite these favorable factors, meropenem may represent a valuable therapeutic option for PA-BSI with severe presentations in this setting since mortality remains substantial (22.5%). Our findings underscore the critical importance of early source control and identify septic shock as a key predictor of mortality even in the setting of IMW. The proposed bedside nomogram model could empower clinicians to identify high-risk patients early, facilitating timely interventions and improving outcomes in this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaPseudomonas aeruginosaPseudomonas InfectionsAgedAged, 80 and overFemaleHumansMaleMiddle AgedAnti-Bacterial AgentsInternal MedicineItalyPrognosisRetrospective StudiesRisk FactorsShock, Septic

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.
  • Tufts University School of Medicine, Boston, MA, United States of America.
  • Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
  • Clinica Malattie Infettive, IRCCS San Martino polyclinic Hospital, Genoa, Italy.
  • Department of Medical Sciences, Internal Medicine, University of Turin, Turin, Italy.
  • Infectious Diseases Unit, IRCCS-Sant'Orsola Polyclinic, Bologna, Italy.

ORCID-Profile: Nour Shbaklo, Nicholas Geremia, Vincenzo Scaglione

Zitieren

APA

Corcione, S., Mornese Pinna, S., Vena, A., Schenone, M., Sanino, M., Pascale, R., Pivetta, E., Giacobbe, D. R., Giannella, M., Shbaklo, N., Giovannenze, F., Geremia, N., Mikulska, M., Bavaro, D., Taddei, E., Scaglione, V., Vassia, V., Fumarola, B., Bartoletti, M., …, & SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) (2025). Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study. PLOS One. https://doi.org/10.1371/journal.pone.0317540

Vancouver

Corcione S, Mornese Pinna S, Vena A, Schenone M, Sanino M, Pascale R, et al. Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study. PLOS One. 2025. doi:10.1371/journal.pone.0317540

BibTeX
@article{Corcione2025,
  author = {Corcione, Silvia and Mornese Pinna, Simone and Vena, Antonio and Schenone, Michela and Sanino, Maura and Pascale, Renato and Pivetta, Emanuele and Giacobbe, Daniele Roberto and Giannella, Maddalena and Shbaklo, Nour and Giovannenze, Francesca and Geremia, Nicholas and Mikulska, Malgorzata and Bavaro, Davide and Taddei, Eleonora and Scaglione, Vincenzo and Vassia, Veronica and Fumarola, Benedetta and Bartoletti, Michele and Viale, Pierluigi and Bassetti, Matteo and Giuseppe De Rosa, Francesco and SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva), SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva)},
  title = {Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0317540}
}
Kostenlos starten →